The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

This publication has 32 references indexed in Scilit:

• Positron emission tomographic imaging of the dopamine transporter with ¹¹C‐WIN 35,428 reveals marked declines in mild Parkinson's disease
  Annals of Neurology, 1993
• In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [¹¹C]tetrabenazine
  Synapse, 1993
• In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain
  Life Sciences, 1992
• Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs
  Psychopharmacology, 1990
• Autoradiographic localization of cocaine binding sites by [³H]CFT ([³H]WIN 35,428) in the monkey brain
  Synapse, 1990
• Modification of vesicular dopamine and norepinephrine by mono amine oxidase inhibitors
  Biochemical Pharmacology, 1989
• Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin
  Neuroscience, 1989
• In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography
  Acta Neurologica Scandinavica, 1987
• L-Dopa Methyl Ester—A Candidate for Chronic Systemic Delivery of L-Dopa in Parkinsonʼs Disease
  Clinical Neuropharmacology, 1984
• Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain
  Science, 1977